Cart
sales@molnova.com
ERK5-IN-1
CAS No. 1234479-76-5
ERK5-IN-1( —— )
Catalog No. M19955 CAS No. 1234479-76-5
ERK5-IN-1 is a potent ERK5 inhibitor (IC50: 87 nM). It also inhibits LRRK2[G2019S] (IC50: 26 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 117 | In Stock |
|
| 5MG | 116 | In Stock |
|
| 10MG | 163 | In Stock |
|
| 25MG | 243 | In Stock |
|
| 50MG | 323 | In Stock |
|
| 100MG | 452 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameERK5-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionERK5-IN-1 is a potent ERK5 inhibitor (IC50: 87 nM). It also inhibits LRRK2[G2019S] (IC50: 26 nM).
-
DescriptionERK5-IN-1 is a potent ERK5 inhibitor (IC50: 87 nM). It also inhibits LRRK2[G2019S] (IC50: 26 nM).
-
In VitroERK5-IN-1 (Compound 5) exhibits a cellular EC50 for inhibiting epidermal growth factor (EGF) induced ERK5 autophosphorylation of 0.19±0.04 μM.
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetERK
-
RecptorERK5
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1234479-76-5
-
Formula Weight459.54
-
Molecular FormulaC25H29N7O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCOc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCN(C)CC1
-
Chemical Name6H-Pyrimido[45-b][14]benzodiazepin-6-one 511-dihydro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-511-dimethyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Deng X et al. Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[54-b]diazepine-6(11H)-ones. Eur J Med Chem. 2013;70:758-767.
molnova catalog
related products
-
BIX02188 (c)
BIX02188 is a selective inhibitor of MEK5 with IC50 of 4.3 nM, also inhibits ERK5 catalytic activity with IC50 of 810 nM.
-
SC1
Pluripotin (SC1) is a dual inhibitor of extracellular signal-regulated kinase 1 (ERK1, MAPK3) and RasGAP. Maintains embryonic stem cell (ESC) self-renewal.
-
Officinalisinin I
Officinalisinin I can effectively reduce the blood glucose and protect nerve injuryin diabetic mice.
